A navigator list for people overdue for cancer screening
Illustrative scenario. This is a composite for planning. It is not a report of a specific peer-reviewed trial.
This is an illustrative composite, not a trial report. A registry ranks patients who are overdue for a fit test, mammogram, or other screening the health system already recommends. Navigators call down the list. Before anyone trusts the rank order, the team checks whether the score under-calls a language group, a neighborhood, or a payer. No detection-rate improvement is claimed. A biased rank can widen a gap the program meant to close.
Clinical setting
A health-system population health team with navigators, working from an existing screening registry rather than from a new disease label.
Tools and vendors
Population health registry
Outreach workqueue
Source
Illustrative composite, Madical AI Use · Mar 18, 2026 · Year 2026
The U.S. CDC National Wastewater Surveillance System publishes pathogen trends from sewage, which health departments read next to emergency and lab data. Some jurisdictions add a statistical nowcast on top of that feed. This card is about the desk workflow, not a claim that a named model forecasts incidence with a stated error. Wastewater is a population signal. It does not diagnose a person.
IDx-DR, now marketed as LumineticsCore by Digital Diagnostics, was authorized to screen adults with diabetes for more-than-mild diabetic retinopathy without an eye specialist reading the photo first. A primary care team captures images on a specified retinal camera and the software returns a refer-or-rescreen result. It is not a complete eye examination. Pregnancy and several existing retinal conditions sit outside the labeled use.
LumineticsCore (IDx-DR) · Digital Diagnostics · Topcon NW400
The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.